Education
About Us
Working with TipRanks
Follow Us
Rossari Biotech Ltd (IN:ROSSARI)
:ROSSARI
ROSSARI Stock Chart & Stats
₹583.95
₹39.25(5.10%)
At close: 4:00 PM EST
₹583.95
₹39.25(5.10%)
Day’s Range― - ―
52-Week Range₹503.85 - ₹767.55
Previous CloseN/A
Volume112.05K
Average Volume (3M)2.66K
Market Cap
₹28.66B
Enterprise Value₹31.26B
Total Cash (Recent Filing)₹1.17B
Total Debt (Recent Filing)₹0.00
Price to Earnings (P/E)20.8
Beta0.87
Next Earnings
Apr 27, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield0.09%
Share Statistics
EPS (TTM)5.90
Shares Outstanding55,383,366
10 Day Avg. Volume1,386
30 Day Avg. Volume2,661
Financial Highlights & Ratios
PEG Ratio5.98
Price to Book (P/B)2.88
Price to Sales (P/S)1.64
P/FCF Ratio-161.88
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Consistent Revenue GrowthSustained mid-teens revenue growth indicates durable demand for speciality formulations and successful commercial expansion. Over 2-6 months this supports scale economics, stronger customer relationships, and continued reinvestment in product development and capacity.
Improved Profitability MarginsMaterial improvement in gross and EBIT margins reflects higher-value speciality products and operational efficiency. These margin levels underpin durable cash-generation potential (subject to capex) and give pricing power versus commodity peers, supporting long-term competitiveness.
Low Leverage And Strong Equity BaseLow leverage and a high equity ratio provide financial flexibility to fund growth, absorb shocks, or pursue M&A without overleveraging. Improved ROE shows effective capital use, strengthening resilience and strategic optionality over the medium term.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow from elevated capex erodes internal funding ability and can force external financing or slower shareholder returns. Over months this constrains runway for organic expansion and increases reliance on balance sheet liquidity despite accounting profits.
Pressure On Operational Cash GenerationA declining EBITDA margin signals emerging pressure on core operating profitability and cash conversion. If sustained, this limits reinvestment capacity and makes free cash flow recovery harder, potentially requiring stricter cost control or pricing actions.
End‑market And Input SensitivityRevenue and margins depend on cyclical textile processing volumes and FMCG/cleaning demand plus volatile raw material costs. This structural exposure can produce sustained revenue and margin swings across quarters, complicating forecasting and capital allocation decisions.
Rossari Biotech Ltd News
ROSSARI FAQ
What was Rossari Biotech Ltd’s price range in the past 12 months?
Rossari Biotech Ltd lowest stock price was ₹503.85 and its highest was ₹767.55 in the past 12 months.
What is Rossari Biotech Ltd’s market cap?
Rossari Biotech Ltd’s market cap is ₹28.66B.
When is Rossari Biotech Ltd’s upcoming earnings report date?
Rossari Biotech Ltd’s upcoming earnings report date is Apr 27, 2026 which is in 63 days.
How were Rossari Biotech Ltd’s earnings last quarter?
Rossari Biotech Ltd released its earnings results on Jan 17, 2026. The company reported ₹5.9 earnings per share for the quarter, missing the consensus estimate of ₹6.2 by -₹0.3.
Is Rossari Biotech Ltd overvalued?
According to Wall Street analysts Rossari Biotech Ltd’s price is currently Overvalued.
Does Rossari Biotech Ltd pay dividends?
Rossari Biotech Ltd pays a Annually dividend of ₹0.5 which represents an annual dividend yield of 0.09%. See more information on Rossari Biotech Ltd dividends here
What is Rossari Biotech Ltd’s EPS estimate?
Rossari Biotech Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Rossari Biotech Ltd have?
Rossari Biotech Ltd has 55,383,366 shares outstanding.
What happened to Rossari Biotech Ltd’s price movement after its last earnings report?
Rossari Biotech Ltd reported an EPS of ₹5.9 in its last earnings report, missing expectations of ₹6.2. Following the earnings report the stock price went up 2.125%.
Which hedge fund is a major shareholder of Rossari Biotech Ltd?
Currently, no hedge funds are holding shares in IN:ROSSARI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Rossari Biotech Ltd
Rossari Biotech Limited engages in manufacture and sale of specialty chemicals in India and internationally. It offers soap and detergents; inks, paints, and coatings; ceramics and tiles; pulp and papers; cement; and water treatment solutions. The company also provides textile specialty chemicals, such as cotton, polyester, acrylic, wool, silk, nylon, functional finishes, denim, and sustainable solutions; and pet grooming products, which include natural pet shampoos, powders, deodorants, sprays, creams, and floor washing liquids under the Lozalo, Hunger Fills, and Sniffy brand names. In addition, it provides poultry nutrition products comprising vitamin-mineral formulations, toxin binders, individual and cocktail enzymes, liquid nutraceuticals, and supplements or herbal preparations. The company was formerly known as Rossari Labtech and changed its name to Rossari Biotech Limited in December 2003. Rossari Biotech Limited was founded in 2003 and is based in Mumbai, India.
Technical Analysis
Bharat Rasayan Limited
―
Fineotex Chemical Limited
―
Kiri Industries Limited
―
Orissa Minerals Development Company Limited
―
Raghav Productivity Enhancers Ltd.
―